Fusen Pharmaceutical Co., Ltd. (1652)

Overview

Fusen Pharmaceutical Company Limited operates as an investment holding entity that has carved a niche in the pharmaceutical manufacturing and sales sector within the People's Republic of China. Since its inception in 2003, the company has been committed to addressing a diversity of health concerns through its impressive array of pharmaceutical products. Headquartered in Nanyang, China, Fusen Pharmaceutical extends beyond manufacturing, engaging in rigorous research and development to produce innovative pharmaceutical solutions. Moreover, the company enriches its core operations with business management and consulting services, reflecting a multifaceted approach to its venture in the healthcare industry.

Products and Services

The product portfolio of Fusen Pharmaceutical Company Limited is comprehensive, catering to a wide range of health conditions. Below is a detailed overview of their major offerings:

• Shuanghuanglian-based Cold Medicines: This includes an array of preparations such as Shuanghuanglian oral solutions and Shuanghuanglian injections, designed to treat cold symptoms effectively.
• Flunarizine Hydrochloride Capsules: Aimed at treating migraines, this medication helps in preventing and reducing the frequency of migraine headaches.
• Compound Ferrous Sulfate Granules: This product is a dietary supplement used in the prevention and treatment of iron-deficiency anemia, helping to replenish iron stores in the body.
• Yuanhu Zhitong Oral Solutions: Specifically developed for pain relief, this solution is used in traditional Chinese medicine to address various types of pain.
• Ganweikang Tablets: Targeted at gastrointestinal diseases, these tablets offer effective relief and treatment for a range of digestive disorders.
• Yixinkang Tablets: Formulated for cardiovascular health, Yixinkang tablets help in treating heart-related conditions, promoting overall cardiac well-being.

In addition to these products, Fusen Pharmaceutical is actively involved in the research, development, production, and sales of proprietary Chinese medicines and Western medicine products. These endeavors aim at combating cold and fever, cardiovascular diseases, and anemia, showcasing the company’s commitment to advancing health outcomes through pharmaceutical innovation. Furthermore, the company's provision of business management and consulting services indicates a holistic approach to its operations, ensuring a remarkable presence in China's healthcare and pharmaceutical landscape.